Skip to main content

Table 5 Bivariate analysis of risk factors associated with Newborn prevalence of GBS, Hawassa University Comprehensive Specialized Hospital, November 2014–March 2015 (n = 280)

From: Prevalence of group B streptococcus among pregnant women and newborns at Hawassa University comprehensive specialized hospital, Hawassa, Ethiopia

Variables Prevalence of GBS, OR(95%CI) P-value
Weight 1000-2499 g 3/32 (9.4%) 1.5 (0.27–9.11) 0.9
2500-4000 g+ 23/260 (8.8%) 1  
APGAR score at 5 min < 7 11/131 (8.4%) 0.83 (0.37–1.9) 0.65
> 7 15/161 (9.3%) 1  
Week of birth < 37 3/28 (10.7%) 0.6 (0.05–7) 0.68
37–42 22/258 (8.5%) 0.47 (0.05–4.37) 0.55
> 42 1/6 (16.7%) 1  
APGAR score at 10 min < 7 5/35 (14.3%) 1.78 (0.62–5) 0.28
> 7 21/257 (8.6%) 1  
Status of newborns at birth Dead 2/12 (16.7%) 2.0 (0.42–9.8) 0.37
Alive 24/280 (8.6%) 1  
Developed EOD Yes 1/5 (20%) 2.5 (0.27–23.3) 0.42
No 25/287 (8.7%) 1  
Other diseasea Yes 4/13 (30.8%) 4.95 (1.41–17.3) 0.012
No 22/279 (7.9%) 1  
  1. N total number of newborn, OR odds ratio, GBS group B Streptococcus, EOD early onset delivery, APGAR appearance, pulse, grimace, activity, respiration
  2. aOther disease include cyanosis, spinal bifida, hydrocephaly